...
首页> 外文期刊>Clinical and experimental allergy : >Peamaclein - A new peach allergenic protein: Similarities, differences and misleading features compared to Pru p 3
【24h】

Peamaclein - A new peach allergenic protein: Similarities, differences and misleading features compared to Pru p 3

机译:Peamaclein-一种新的桃子过敏原蛋白:与Pru p 3相比的相似性,差异和误导性特征

获取原文
获取原文并翻译 | 示例

摘要

Background: Among the peach-derived allergens which are already known, the lipid transfer protein (Pru p 3) seems to be the one to exert severe allergic reactions. Objective: To identify and characterize a new peach allergen causing a clinical picture similar to that of Pru p 3. Methods: Patients were selected on the basis of their severe clinical reactivity and negative results to a panel of peach allergens available on the ISAC103 microarray. Several in-house and commercial preparations were compared. Several methods were used to characterize the newly identified molecule. Specific IgE and inhibition assays were performed using the Allergen micro-Beads Array (ABA) assay. Results: Negative ISAC results to Pru p 3 were confirmed by additional testing in contrast with the positive results obtained by commercial Pru p 3-enriched peach peel extracts. The analyses of one of these preparations led to the identification of Peamaclein, a new allergenic protein. It is a small, basic, cysteine-rich, heat-stable, digestion-resistant protein, homologous to a potato antimicrobial peptide. Peamaclein was able to trigger positive skin test reactions and to bind IgE in the ABA assay. It displays an electrophoretic mobility and chromatographic behaviour similar to that of Pru p 3; therefore, it can be hidden in Pru p 3 preparations. In fact, Pru p 3-enriched peach peel extracts were found to contain both Pru p 3 and Peamaclein by means of comparative in vivo testing, and by biochemical and immunochemical assays. Commercially available anti-Pru p 3 polyclonal antibodies were found to have a double specificity for the two molecules. Conclusions and Clinical Relevance: A new allergen from peach belonging to a new family of allergenic proteins has been identified and characterized. This knowledge on Peamaclein will improve our understanding on the clinical aspects of the peach allergy and the quality of diagnostic reagents.
机译:背景:在已知的桃子过敏原中,脂质转移蛋白(Pru p 3)似乎是发生严重过敏反应的一种。目的:鉴定和表征引起与Pru p 3相似的临床症状的新桃子过敏原。方法:根据严重的临床反应性和对ISAC103微阵列上可用的一组桃子过敏原的阴性结果选择患者。比较了几种室内和商业制剂。使用了几种方法来表征新鉴定的分子。使用过敏原微珠阵列(ABA)分析进行特异性IgE和抑制分析。结果:与其他富含Pru p 3的桃皮提取物获得的阳性结果相比,通过额外的测试证实了ISAC对Pru p 3的阴性结果。对其中一种制剂的分析导致鉴定了一种新的致敏蛋白Peamaclein。它是一种小的,基本的,富含半胱氨酸的,热稳定的,抗消化的蛋白质,与马铃薯抗菌肽同源。 Peamaclein能够触发积极的皮肤测试反应,并在ABA分析中结合IgE。它显示的电泳迁移率和色谱行为与Pru p 3相似。因此,它可以隐藏在Pru p 3准备中。实际上,通过比较体内试验,生化和免疫化学分析,发现富含Pru p 3的桃皮提取物同时含有Pru p 3和Peamaclein。发现可商购的抗Pru p 3多克隆抗体对两个分子具有双重特异性。结论和临床意义:已经鉴定并鉴定了来自桃子的一种新的过敏原,该过敏原属于一个新的致敏蛋白家族。对Peamaclein的了解将增进我们对桃子变态反应的临床方面和诊断试剂质量的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号